The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - IMPaRT.ai
Consulting or Advisory Role - Acrotech Biopharma; Crispr Therapeutics; Pfizer; Salarius Pharmaceuticals; Seagen; Secura Bio; Yingli Pharma
Research Funding - Acrotech Biopharma; AstraZeneca; Crispr Therapeutics; Innate Pharma; Legend Biotech; Merck; Ono Pharmaceutical; Pfizer; Seagen; Trillium Therapeutics; Yingli Pharma
Other Relationship - IMPaRT.ai
Frontline brentuximab vedotin (BV) and CHP in patients (pts) with peripheral T-cell lymphoma (PTCL) with <10% CD30 expression: Primary analysis results from the phase 2 SGN35-032 study.
 
Swaminathan Iyer
No Relationships to Disclose
 
Deepa Jagadeesh
Consulting or Advisory Role - AFM; Daiichi Sankyo/Lilly; Genmab
Research Funding - ADC Therapeutics (Inst); AstraZeneca (Inst); Debiopharm Group (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); MEI Pharma (Inst); Merck (Inst); Regeneron (Inst); Rhizen Pharmaceuticals (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Eva Domingo-Domenech
Consulting or Advisory Role - BeiGene; Takeda
Speakers' Bureau - BeiGene; Takeda
Research Funding - Bristol-Myers Squibb; Takeda
Travel, Accommodations, Expenses - Takeda
 
Fabio Benedetti
No Relationships to Disclose
 
Antonia Rodriguez Izquierdo
Honoraria - Takeda
Consulting or Advisory Role - MERCK SHARP & DOHME DE ESPAÑA, S.A.
Research Funding - Abbvie; Astex Pharmaceuticals; MERCK SHARP & DOHME DE ESPAÑA, S.A; Pfizer; Roche; Seagen; Viracta Therapeutics
Travel, Accommodations, Expenses - BeiGene; Takeda
 
Kamal Bouabdallah
Honoraria - Abbvie; BeiGene; Kite/Gilead; Roche; Sandoz-Novartis; Takeda Science Foundation
Consulting or Advisory Role - BeiGene; Kite/Gilead; Lilly; Roche; Sandoz; Takeda
Travel, Accommodations, Expenses - BeiGene; Kite/Gilead; Roche; Takeda
 
Umberto Vitolo
Consulting or Advisory Role - Abbvie; Genmab; Gilead Sciences; Incyte; Regeneron
Speakers' Bureau - Abbvie; Genmab; Gilead Sciences; Incyte; MSD Oncology; Regeneron; Roche; SERVIER
Research Funding - Morphosys (Inst)
Travel, Accommodations, Expenses - Abbvie; Incyte
 
Tim Illidge
Travel, Accommodations, Expenses - ICML Conference
 
Jingmin Liu
Employment - Pfizer; Seagen
Stock and Other Ownership Interests - Pfizer; Seagen
Travel, Accommodations, Expenses - Pfizer; Seagen
 
Eeman Shaikh
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer (I)
 
Steven Horwitz
Honoraria - seagen
Consulting or Advisory Role - Abcuro; Arvinas; Autolus Therapeutics; Auxilius Pharma; Corvus Pharmaceuticals; DAAN Biotherapeutics; Daiichi Sankyo; J&J Medicine/Janssen Research & Development; Kyowa Hakko Kirin; MarchBIO; Ono Pharmaceutical; Pfizer; Secura Bio; Shoreline Biosciences; SymBio Pharmaceuticals; Takeda
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); Celgene (Inst); crispr therapeutics (Inst); Daiichi Sankyo (Inst); Kyowa Kirin International (Inst); Seagen (Inst); Secura Bio (Inst); Takeda (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - SeaGen; Takeda